Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
about
Aspirin intake and survival after breast cancerProspective evaluation of analgesic use and risk of renal cell cancerPlatelets, coagulation and fibrinolysis in breast cancer progressionBreast cancer chemoprevention: old and new approachesNovel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast cancerMedical prevention of breast cancerCyclooxygenase-2 and cancer treatment: understanding the risk should be worth the rewardNon-Steroidal Anti-Inflammatory Drug Use and Genomic DNA Methylation in BloodCardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological preventionChallenges in the Treatment of Triple Negative and HER2-Overexpressing Breast CancerBacteria peptidoglycan promoted breast cancer cell invasiveness and adhesiveness by targeting toll-like receptor 2 in the cancer cellsCurrent strategies for the prevention of breast cancerAn association between anti-platelet drug use and reduced cancer prevalence in diabetic patients: results from the Vermont Diabetes Information System StudyRegular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study.Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapyMigraine history and breast cancer risk among postmenopausal women.Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice Research Datalink.Analgesic use and sex steroid hormone concentrations in postmenopausal women.Microbial carcinogenic toxins and dietary anti-cancer protectants.COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatmentPrescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control studyAspirin use and survival after the diagnosis of breast cancer: a population-based cohort studySpecialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort.Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women.Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study.Aspirin and serum estrogens in postmenopausal women: a randomized controlled clinical trial.Overexpression of COX-2 in celecoxib-resistant breast cancer cell lines.Platelets and cancer: a casual or causal relationship: revisited.Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studiesGenetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study.DEXA measures of body fat percentage and acute phase proteins among breast cancer survivors: a cross-sectional analysis.Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis.Arachidonic acid and cancer risk: a systematic review of observational studies.Urinary prostaglandin E2 metabolite and breast cancer risk.Evaluation of relationship between breast cancer and migraine.Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancerThe role of aspirin in women's healthNonsteroidal anti-inflammatory drug and acetaminophen use and risk of adult myeloid leukemia.Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype.
P2860
Q24604280-447EFA5A-71D1-4989-A842-19B60CB09D76Q24608512-1E5E13D5-BCE0-47DF-8D7D-E46958B0E481Q26823716-B9C2708F-49CA-4549-A149-32A25D9038CCQ27693259-645CA3D3-13D1-41AE-921A-5663DE82BC41Q28066348-4C11106E-BBBB-4604-A3BD-1EC0FA9861EFQ28086915-DF8C5177-A3FD-47E8-8792-C7E6D8645634Q28274081-943BAFFD-3880-460D-8747-D3D8648509F0Q28548336-2C72F0A2-40D0-461A-BA73-7AF774C5E4B3Q33574045-FCC211F0-4412-43E5-8C58-1660256A42FDQ33576608-B7B4FB89-CCF9-4E71-9113-37A0A81E5474Q33592943-A780E5A6-E9F6-469E-B83A-B023F2BE74A5Q33599463-DE258905-5A9A-4F4E-BD6F-65CBE7337C79Q33603788-33414645-5689-4643-827C-056101090CE8Q33619700-F15C1B80-B7F2-4991-8DE1-877A58DB6CCEQ33686719-DDB00FC4-9C01-422E-920D-C1044EF71819Q33710703-A84F9611-2C7D-4A57-84AC-CA9270D3F31EQ33739454-E4B2E65C-1C09-4C17-A360-4420DD479306Q33780860-B5DAE191-BBF6-4BB6-ACFE-33E941FE002DQ33844512-8972410E-58DA-4B49-BD3A-189E22DE1A71Q33877411-C9037A05-9278-4B49-A33A-00B26949B579Q33889458-FFD6F3CB-05F7-488C-BBD5-295576546775Q33994275-CA0039C4-A563-4C8F-ACE9-D6C93AA6D335Q34003218-DD26F4EF-2113-415B-997C-D508C2985360Q34034263-D07C97FF-8E31-4B46-B97F-F244C3E9D4C0Q34069337-715E37B5-7769-48C7-BFD2-8157A57F5F67Q34135505-AEE6ADB1-D8AF-4C08-8446-F0DB32230153Q34143022-DE1BB204-B4A4-4437-B743-11997A6347D1Q34294719-E63BC424-6DD0-497F-AC8C-4A4A6089C88FQ34327296-7D03CBB2-5D44-47CB-A68B-44AD01E97437Q34351250-2FA5AD02-CBF9-4C3A-8498-58BEBAFF635BQ34370972-1364B87D-C76F-4F34-B0C2-4A5188776C70Q34458235-E534E5EF-C93E-4272-8494-E319170C45ACQ34514980-7F101386-5187-4720-9F5F-5D1785E39894Q34641787-160BCEC5-4926-4896-A030-ABA03D6E9BBAQ34990867-28AA7E55-43EB-4457-A24B-61BC82413A83Q34996098-8AFA8035-9964-430A-8EA3-43210949F8CAQ35108403-9BD207C8-FB75-4AB6-8C5E-32D1B7C0E211Q35119642-BB2108F3-D385-4BBD-8CA4-7F904AB3F44FQ35156722-48389B97-7930-44EA-85F4-FFE91A14A408Q35227086-25843A1D-7EBF-48F5-B791-B1C57F6E23F8
P2860
Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
@en
type
label
Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
@en
prefLabel
Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
@en
P2093
P2860
P356
P1476
Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
@en
P2093
Bahi Takkouche
Carlos Regueira-Méndez
Mahyar Etminan
P2860
P304
P356
10.1093/JNCI/DJN324
P407
P577
2008-10-07T00:00:00Z